Autoimmune hepatitis in Italy: The Bologna experience

Journal of Hepatology

Volumn 50, Issue 6, 2009, Pages 1210-1218

  Muratori, Paolo ^a   Granito, Alessandro ^a   Quarneti, Chiara ^a   Ferri, Silvia ^a   Menichella, Rita ^a   Cassani, Fabio ^a   Pappas, Georgios ^a   Bianchi, Francesco B ^a   Lenzi, Marco ^a   Muratori, Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoimmunity; Liver; Therapy

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; HEPATITIS B SURFACE ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHEMICAL ANALYSIS; CHOLESTASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; EXPERIENCE; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL MONITORING; ITALY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SEX RATIO; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; AGE FACTORS; CHILD, PRESCHOOL; FEMALE; HEPATITIS, AUTOIMMUNE; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ITALY; MALE; MIDDLE AGED; PROGNOSIS; SEX CHARACTERISTICS; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349254165     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.01.020     Document Type: Article

References (47)

1. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
2. Manns M.P., and Vogel A. Autoimmune hepatitis, from mechanisms to therapy. Hepatology 43 (2006) S132-S144
3. Czaja A.J. Treatment strategies in autoimmune hepatitis. Clin Liver Dis 6 (2002) 799-824
4. Cassani F., Muratori L., Manotti P., Lenzi M., Fusconi M., Ballardini G., et al. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut 33 (1992) 1260-1263
5. Muratori P., Muratori L., Agostinelli D., Pappas G., Veronesi L., Granito A., et al. Smooth muscle antibodies and type 1 autoimmune hepatitis. Autoimmunity 35 (2002) 497-500
6. Czaja A.J., Morshed S.A., Parveen S., and Nishioka M. Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis. Hepatology 26 (1997) 567-572
7. Zauli D., Ghetti S., Grassi A., Descovich C., Cassani F., Ballardini G., et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 25 (1997) 1105-1107
8. Kanzler S., Weidemann C., Gerken G., Lohr H.F., Galle P.R., Meyer zum Buschenfelde K.H., et al. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 31 (1999) 635-640
9. Homberg J.C., Abuaf N., Bernard O., Islam S., Alvarez F., Khalil S.H., et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 7 (1987) 1333-1339
10. Martini E., Abuaf N., Cavalli F., Durand V., Johanet C., and Homberg J.C. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 8 (1988) 1662-1666
11. Muratori L., Cataleta M., Muratori P., Lenzi M., and Bianchi F.B. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis. Gut 42 (1998) 721-726
12. Mackay I.R., Weiden S., and Hasker J. Autoimmune hepatitis. Ann NY Acad Sci 124 (1965) 767-780
13. Johnson P.J., and McFarlane I.G. Meeting report: international autoimmune hepatitis group. Hepatology 18 (1993) 998-1005
14. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
15. Hennes E.M., Zeniya M., Czaja A.J., Pares A., Dalekos G.N., Krawitt E.L., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48 (2008) 169-176
16. Maddrey W.C. How many types of autoimmune hepatitis are there?. Gastroenterology 105 (1993) 1571-1575
17. Czaja A.J., and Manns M.P. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 90 (1995) 1206-1211
18. Czaja A.J., and Donaldson P.T. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol 97 (2002) 2051-2057
19. Miyake Y., Iwasaki Y., Sakaguchi K., and Shiratori Y. Clinical features of Japanese male patients with type 1 autoimmune hepatitis. Aliment Pharmacol Ther 24 (2006) 519-523
20. Al-Chalabi T., Underhill J.A., Portmann B.C., McFarlane I.G., and Heneghan M.A. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 48 (2008) 140-147
21. Verslype C., George C., Buchel E., Nevens F., van Steenbergen W., and Fevery J. Diagnosis and treatment of autoimmune hepatitis at age 65 and older. Aliment Pharmacol Ther 21 (2005) 695-699
22. Granito A., Muratori L., Pappas G., Muratori P., Ferri S., Cassani F., et al. Clinical features of type 1 autoimmune hepatitis in elderly Italian patients. Aliment Pharmacol Ther 21 (2005) 1273-1277
23. Miyake T., Miyaoka H., Abe M., Furukawa S., Shigematsu S., Furukawa E., et al. Clinical characteristics of autoimmune hepatitis in older aged patients. Hepatol Res 36 (2006) 139-142
24. Floreani A., Niro G., Rosa Rizzotto E., Antoniazzi S., Ferrara F., Carderi I., et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicentre study. Aliment Pharmacol Ther 24 (2006) 1051-1057
25. Al-Chalabi T., Boccato S., Portmann B.C., McFarlane I.G., and Heneghan M.A. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 45 (2006) 575-583
26. Miyake Y., Iwasaki Y., Terada R., Takagi S., Okamaoto R., Ikeda H., et al. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis. J Hepatol 43 (2005) 951-957
27. Heathcote J. Treatment strategies for autoimmune hepatitis. Am J Gastroenterol 101 (2006) S630-S632
28. Al-Chalabi T., and Heneghan M.A. Remission in autoimmune hepatitis: what is it, and can it ever be achieved?. Am J Gastroenterol 102 (2007) 1013-1015
29. Montano-Loza A.J., Carpenter H.A., and Czaja A.J. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse. Am J Gastroenterol 102 (2007) 1005-1012
30. Cassani F., Cataleta M., Valentini P., Muratori P., Giostra F., Francesconi R., et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26 (1997) 561-566
31. Lenzi M., Manotti P., Muratori L., Cataleta M., Ballardini G., Cassani F., et al. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 36 (1995) 749-754
32. Vergani D., Alvarez F., Bianchi F.B., Cancado E.L., Mackay I.R., Manns M.P., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 41 (2004) 677-683
33. Muratori L., Lenzi M., Ma Y., Cataleta M., Mieli-Vergani G., Vergani D., et al. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut 37 (1995) 406-412
34. Czaja A.J., and Freese D.K. Diagnosis and treatment of autoimmune hepatitis. Hepatology 36 (2002) 479-497
35. Ferrari R., Pappas G., Agostinelli D., Muratori P., Muratori L., Lenzi M., et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. Qjm 97 (2004) 407-412
36. Czaja A.J., Kruger M., Santrach P.J., Moore S.B., and Manns M.P. Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol 92 (1997) 2197-2200
37. Bittencourt P.L., Goldberg A.C., Cancado E.L., Porta G., Carrilho F.J., Farias A.Q., et al. Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol 94 (1999) 1906-1913
38. Underhill J., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., and Vergani D. Different immunogenetic background in autoimmune hepatitis type 1, type 2 and autoimmune sclerosing cholangitis. J Hepatol 36 (2002) 156
39. Gregorio G.V., Portmann B., Reid F., Donaldson P.T., Doherty D.G., McCartney M., et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25 (1997) 541-547
40. Duchini A., McHutchison J.G., and Pockros P.J. LKM-positive autoimmune hepatitis in the western United States: a case series. Am J Gastroenterol 95 (2000) 3238-3241
41. Verma S., Gunuwan B., Mendler M., Govindrajan S., and Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 99 (2004) 1510-1516
42. Feld J.J., Dinh H., Arenovich T., Marcus V.A., Wanless I.R., and Heathcote E.J. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 42 (2005) 53-62
43. Czaja A.J., Carpenter H.A., Santrach P.J., and Moore S.B. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105 (1993) 1502-1507
44. Verma S. In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases?. J Hepatol 44 (2006) 819-820; author reply 820-811
45. Montano-Loza A.J., Carpenter H.A., and Czaja A.J. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver Int 27 (2007) 507-515
46. Czaja A.J., Bianchi F.B., Carpenter H.A., Krawitt E.L., Lohse A.W., Manns M.P., et al. Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 41 (2005) 207-215
47. Hennes E.M., Oo Y.H., Schramm C., Denzer U., Buggisch P., Wiegard C., et al. Mycophenolate mofetil as second line therapy in autoimmune hepatitis?. Am J Gastroenterol 103 (2008) 3063-3070